Modifications

* 10:25 AM - 10:55 AM: Development of bacteriophages targeted against Borrelia burgdorferi. Louis Teulières, France. [membre de l'[[ILADS]]]

* 10:25 AM - 10:55 AM: Development of bacteriophages targeted against Borrelia burgdorferi. Louis Teulières, France. [membre de l'[[ILADS]]]

* 11:35 AM - 12:20 PM: Treatment of Persistent Lyme Disease and Co-Infections. Use of Antiparasitic, Antifungal and Anti-Mycobacterial Drugs [[Richard Horowitz|Richard I. Horowitz]], MD

* 11:35 AM - 12:20 PM: Treatment of Persistent Lyme Disease and Co-Infections. Use of Antiparasitic, Antifungal and Anti-Mycobacterial Drugs [[Richard Horowitz|Richard I. Horowitz]], MD

* 1:00 PM - 1:30 PM: Diagnosis of Borreliosis (Lyme Disease and Relapsing Fever) in US and Europe by Immune-Blots Jyotsna S. Shah, PhD [Directrice de la recherche et du dévelopement du [[Nick Harris|laboratoire IGeneX]]]; Mariia Shkilna, MD, PhD

* 1:00 PM - 1:30 PM: Diagnosis of Borreliosis (Lyme Disease and Relapsing Fever) in US and Europe by Immune-Blots [[Nick Harris|Jyotsna S. Shah]], PhD [Directrice de la recherche et du dévelopement du [[Nick Harris|laboratoire IGeneX]]]; Mariia Shkilna, MD, PhD

* 1:30 PM - 2:00 PM: Selected Oral Abstracts John S. Lambert, MD, PhD; Kati Karvonen, MSc; Rosemarie Preyer, Dipl

* 1:30 PM - 2:00 PM: Selected Oral Abstracts John S. Lambert, MD, PhD; Kati Karvonen, MSc; Rosemarie Preyer, Dipl

* 2:00 PM - 2:25 PM: Complex Chronic Infections in Autistic Children Laura Alonso, MD [Spain]

* 2:00 PM - 2:25 PM: Complex Chronic Infections in Autistic Children Laura Alonso, MD [Spain]